Herbal medicines and their bioactive metabolites as potential anticancer agents

  • 4,303

    Total downloads

  • 15k

    Total views and downloads

About this Research Topic

Submission closed

Background

The various forms of cancer are undeniably a pandemic, and the rate at which some cancers are spreading worldwide quickly outpaces efforts to stop it. It is one of the most life-threatening problems of the 21st century. In 2018, there were 17 million new cases, with 9.6 million fatalities. More than 19 million new cancer cases will be diagnosed globally by 2020, and more than 10 million people will have died due to cancer. If current trends continue, there will be 27.5 million new cancer patients annually by 2040. Also, in many countries, often cancers remain undiagnosed and untreated, and thus, the real numbers are certainly higher.

The different types of cancer are caused by many factors, both intrinsic, like gene mutations, hormones, and the immune system and extrinsic. The latter includes factors like smoking, eating habits, radiation, and infectious organisms. Over the years, the number of drugs used to prevent or treat cancer has grown significantly. Patients may experience some unexpected side effects due to current treatment methods. Also, the rapid emergence of resistance and the high cost of treatment make them ineffective for the overall treatment of cancer. Even though there have been improvements in the development of synthetic anticancer drugs in the past few years, cancer patients have been waiting for bettermedicines that is easier to administer, costs less, has fewer side effects, and reduce the risk of developing resistance.

The use of herbal medical products and medicines derived from natural products has gained more attention in treating cancer due to their multiple-targeted sites, ease of access, greater chemo-sensitization, economy, less toxic effects, and lack of drug resistance. Some core anti-cancer medicines are derived from plant or fungal metabolites. However, the current medicines have several limitations in terms of their use, including their formulation, solubility, and half-life. Thus, new therapeutic strategies are required to overcome drug resistance, with greater efficacy and selectivity, and with fewer toxic effects. Globally, medicinal plants(MPs) have been essential parts of pharmacotherapy, also in treating cancer. MPs have contributed significantly to the advancement of cancer therapy. Also, some metabolites are thought to be essential inchemopreventive interventions. Therefore, it is crucial to develop pioneering strategies to improve cancer curestreatment and to develop strategies for better chemoprevention. Hence, medicinal plants remain a significant resource for developing novel anticancer treatments. A different and less well developed line of research is the search for preventive interventions reducing the cancer risks in populations
With a particular view on the advances in omics technologies and improved drug delivery systems, this Research Topic brings together recent research on the role of medicinal plants / fungi and their metabolites in the prevention and treatment of cancer (including both manuscripts covering original research and reviews). Also welcome are contributions which allow a better understanding of the biological mechanisms underlying these treatments across a variety of disciplinary topics are, the current state of knowledge on the study of plant-based anticancer agents, the discovery of novel bioactive metabolites, the evaluation of their anticancer activity in vitro and in vivo, the investigation of their pharmacological mechanisms of action, and the advances in research on semisynthetic derivatives with improved activity.

This Research Topic covers the following topics:

● Identification of anticancer agents in medicinal plants.
● Mechanism of action of herbal products and their lead metabolites on cancer.
● Assessing medicinal plant extracts and their metabolites for cancer preventive activity using established in vitro or in vivo models.
● Novel and improved formulation of herbal products for cancer treatment.
Reviews and meta-analyses of natural product effectiveness and their metabolites.
● Pharmacological and toxicological studies.
● Identifying the credible bioactive metabolites in ethnopharmacologically documented cancer medicines using system biology and metabolomic approaches if these studies are conducted in combination with pharmacological evaluations using an experimental (in vitro and in vivo) approach.



All the manuscripts submitted to the collection will need to fully comply with the Four Pillars of Best Practice in Ethnopharmacology (you can freely download the full version here). chemical anti-oxidant assays like the DPPH assay are of no pharmacological relevance, see also: http://cms.herbalgram.org/heg/volume15/01January/JournalsSkepticalofAssays.html. These are simply chemical tests / analytical tools and there is no evidence for therapeutic benefits on the basis of such chemical assays. The ethnopharmacological context must be spelled out clearly using primary sources. Purely in silico studies are not considered.

Research Topic Research topic image

Keywords: anti-cancer drugs, ethnopharmacological treatment, traditional healthcare, natural medicine

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Frequently asked questions

  • Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

    Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

  • The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

    Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

  • As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

    A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

  • Each Research Topic must be approved by the specialty chief editor, and it falls under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

    In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

  • Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

    As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

    Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

  • Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

    Check available article types here 

  • Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

    Suggest your topic here 

  • A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

    The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

  • As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

    You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

  • As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

  • If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

  • Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

  • Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

  • As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

    Find out more about our Research Topics

  • Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

    Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

  • In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.

Participating Journals

Impact

  • 15kTopic views
  • 10kArticle views
  • 4,303Article downloads
View impact